Triumph Capital Management’s Harte-Hanks HHS Stock Holding History

Triumph Capital Management’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$391	Hold	86	–	–	﹤0.01%	1803
2026 Q2	$186	Hold	86	–	–	﹤0.01%	1805
2026 Q1	$195	Hold	86	–	–	﹤0.01%	1767
2025 Q4	$259	Buy	+86	New	+$281	﹤0.01%	1711

Other funds holding HHS

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Covestor London, United Kingdom $157M AUM 35.87% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Triumph Capital Management's HHS Position: Q3 2026 in Review

Triumph Capital Management held its Harte-Hanks (HHS) position steady in Q3 2026 at 86 shares worth $391. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Triumph Capital Management first reported a position in HHS in Q4 2025 and has held it in 4 quarters since. 7 funds tracked by Wall St. Rank hold HHS as of Q3 2026.

Triumph Capital Management held 86 shares of Harte-Hanks worth $391 as of Q3 2026.
Triumph Capital Management left its Harte-Hanks share count unchanged in Q3 2026.
Harte-Hanks made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1803 holding.
Triumph Capital Management first reported a position in Harte-Hanks in Q4 2025 and has held it in 4 quarters since.
7 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.